Abstract:Upper gastrointestinal distress following ambulatory surgery discharge comprises a different symptom mix than during other high-risk events such as pregnancy or chemotherapy. Further research on the differences in assessing NVR among different populations is indicated.
“…Rhodes et al [16] developed an index of nausea and vomiting to capture the multidimensional features of upper gastrointestinal distress. The Rhodes index was tested and found to be a valid and reliable instrument for measuring upper gastrointestinal distress in ambulatory surgical patients [10]. In the present study, a modifi ed Rhodes index was used instead of a simple numeric rating scale to measure the effi cacy of ramosetron.…”
Section: Discussionmentioning
confidence: 99%
“…Complete response (i.e., emesisfree) was defi ned as no PONV and no need for another rescue antiemetic medication. At the end of each observation period, patients evaluated the severity of PONV using a modifi ed Rhodes index (Table 1) [10,11]. At the end of study period, patients evaluated general satisfaction using a linear numerical scale ranging from 0 (complete dissatisfaction) to 10 (complete satisfaction).…”
The effect of oral ramosetron 0.1 mg was comparable to that of IV ramosetron 0.3 mg on the prevention of PONV in women undergoing gynecological laparoscopy with TIVA. Both the oral and IV forms were effective at preventing PONV during the first 1 h after surgery.
“…Rhodes et al [16] developed an index of nausea and vomiting to capture the multidimensional features of upper gastrointestinal distress. The Rhodes index was tested and found to be a valid and reliable instrument for measuring upper gastrointestinal distress in ambulatory surgical patients [10]. In the present study, a modifi ed Rhodes index was used instead of a simple numeric rating scale to measure the effi cacy of ramosetron.…”
Section: Discussionmentioning
confidence: 99%
“…Complete response (i.e., emesisfree) was defi ned as no PONV and no need for another rescue antiemetic medication. At the end of each observation period, patients evaluated the severity of PONV using a modifi ed Rhodes index (Table 1) [10,11]. At the end of study period, patients evaluated general satisfaction using a linear numerical scale ranging from 0 (complete dissatisfaction) to 10 (complete satisfaction).…”
The effect of oral ramosetron 0.1 mg was comparable to that of IV ramosetron 0.3 mg on the prevention of PONV in women undergoing gynecological laparoscopy with TIVA. Both the oral and IV forms were effective at preventing PONV during the first 1 h after surgery.
“…The major goal of patient management in daycase surgery is to promote patient comfort and satisfaction by reducing the anticipated side effects of surgery and anaesthesia. A number of studies concentrate on these side effects and comfort questions [ 26,27], especially pain [28,29] and nausea and vomiting [30]. Safety in day-case surgery operations has also been one of the main interests in these studies [31].…”
Although there were increases and decreases within items of the EQ-5D, overall, there was no improvement on EQ-5D scores. More research is needed to explore the sensitivity and responsiveness of the EQ-5D measure in day-case surgery patients.
“…The AS-INVR, an instrument based on Rhodes Index of Nausea and Vomiting (INV), 44 was modified for use in the ambulatory surgery population. The Rhodes INV was developed to separately measure the patient's perception of nausea and vomiting.…”
Section: Resultsmentioning
confidence: 99%
“…One study defined vomiting as ''emesis or retching.'' 29 Fetzer et al 22,44 determined that retching was not as significant a problem for the PONV/PDNV population as for the pregnant and cancer populations.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.